VolitionRx Limited Other Nonoperating Expense
VolitionRx Limited (VNRX) reported Other Nonoperating Expense of -$196.96 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2020-05-07
- VolitionRx Limited other nonoperating expense for the quarter ending 2019-12-31 was $26.85K.
- VolitionRx Limited other nonoperating expense for the quarter ending 2019-09-30 was -$4.66K.
- VolitionRx Limited other nonoperating expense for the quarter ending 2019-06-30 was -$33.12K.
- VolitionRx Limited other nonoperating expense for the quarter ending 2019-03-31 was -$196.96K.
- VolitionRx Limited other nonoperating expense for fiscal 2019 was -$196.96K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 3 month as first filed | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $26.85K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $22.19K derived: sum of 2 quarters · filed 2020-02-20 | -$10.92K derived: sum of 3 quarters · filed 2020-02-20 | -$196.96K 10-K · filed 2020-02-20 | |
| 2019-09-30 | -$4.66K 10-Q · filed 2019-11-12 | -$37.77K derived: sum of 2 quarters · filed 2019-11-12 | -$223.81K 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | -$33.12K 10-Q · filed 2019-08-12 | -$260.17K 10-Q · filed 2019-08-12 | |||
| 2019-03-31 | -$196.96K 10-Q · filed 2020-05-07 | $196.96K 10-Q · filed 2019-05-08 | |||
| 2018-09-30 | -$29.11K 10-Q · filed 2019-11-12 | -$55.66K derived: sum of 2 quarters · filed 2019-11-12 | -$78.65K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$26.56K 10-Q · filed 2019-08-12 | -$49.54K 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |